psychiatrist.com logo

Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice

Three experts on the treatment of schizophrenia participated in a recent series of teleconferences to discuss current evidence on the management of adverse effects via elective changes in oral antipsychotics. The goal of the project was to provide updated guidance based on findings that have become available since the publication of the 2009 Patient Outcomes Research Team (PORT) psychopharmacological treatment recommendations.

John W. Newcomer, MD, Series Chair

John W. Newcomer, MD, Series Chair

Executive Vice Dean, Charles E. Schmidt College of Medicine,

Florida Atlantic University, Boca Raton, Florida

Peter J. Weiden, MD 

Peter J. Weiden, MD

Professor of Psychiatry, University of Illinois at Chicago

 

Robert W. Buchanan, MD 

Robert W. Buchanan, MD

Professor of Psychiatry, University of Maryland School of Medicine

Interim Director, Maryland Psychiatric Research Center, Baltimore, Maryland

Psychiatrist.com The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders The CME Institute Neurology Knowledge Terms of Use Privacy Policy